PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy
PACIFIC-5:一项针对不可切除的 III 期非小细胞肺癌患者,在同步或序贯放化疗后未出现疾病进展的情况下,进行度伐利尤单抗巩固治疗的 III 期临床试验
期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-025-01768-1
Wu, Yi-Long; Wu, Lin; Bi, Nan; Cil, Timucin; Ge, Hong; Zhu, Zhengfei; Wang, Chih-Liang; Zhang, Wei; Lv, Dongqing; Mingyan, E; Sun, Jianguo; Pan, Yi; Krzakowski, Maciej; Dikilitas, Mustafa; Sendur, Mehmet Ali Nahit; Kim, Young-Chul; Yang, Yanjiao; Mao, Rui; Zhang, Biao; Wang, Luhua